Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:September 16, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:September 16, 2021Terminated
Condition(s):Glomerulonephritis; Focal Segmental GlomerulosclerosisLast Updated:February 19, 2018Completed
Condition(s):Focal Segmental Glomerulosclerosis; Minimal Change DiseaseLast Updated:December 1, 2020Completed
Condition(s):Kidney Transplantation; Primary Focal Segmental Glomerulosclerosis (FSGS)Last Updated:June 14, 2022Completed
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:July 31, 2019Terminated
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:August 11, 2009Unknown status
Condition(s):Focal Segmental Glomerulosclerosis; Chronic Kidney DiseasesLast Updated:January 28, 2020Completed
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:March 8, 2023Recruiting
Condition(s):Glomerulosclerosis, Focal SegmentalLast Updated:July 10, 2023Completed
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:December 4, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.